|
|
|
Volumn 23, Issue 4 SUPPL. 9, 1996, Pages 33-38
|
|
Aromatase inhibitors in clinical practice: Current status and a look to the future
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
ESTROGEN;
EXEMESTANE;
FADROZOLE;
FORMESTANE;
LETROZOLE;
PYRIDOGLUTETHIMIDE;
VOROZOLE;
BREAST CANCER;
CANCER HORMONE THERAPY;
CANCER INHIBITION;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
ENZYME INHIBITION;
FEMALE;
HORMONAL REGULATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
META ANALYSIS;
PATIENT SELECTION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
NEOPLASM METASTASIS;
NEOPLASMS, HORMONE-DEPENDENT;
|
|
EID: 0029783837
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (28)
|
|
References (0)
|
